We are here to assist you.
Health Advisor
+91-8877772277Available 7 days a week
10:00 AM – 6:00 PM to support you with urgent concerns and guide you toward the right care.
Join our healthcare community
Explore Korlym side effects in detail, including common, serious, and rare adverse reactions. Learn when to seek medical help, understand drug interactions, and find answers to FAQs for safe management of Cushing's syndrome treatment.
Korlym, with its active ingredient mifepristone, is a prescription medication primarily used to control hyperglycemia (high blood sugar) in adults with endogenous Cushing's syndrome who also have type 2 diabetes mellitus or glucose intolerance, and who have failed surgery or are not candidates for surgery. Cushing's syndrome is a rare condition caused by prolonged exposure to high levels of cortisol, a steroid hormone. This excess cortisol can lead to a range of symptoms, including high blood sugar, high blood pressure, obesity, muscle weakness, and skin changes. Korlym works differently from many other diabetes medications. Instead of directly affecting insulin or glucose production, it acts as a glucocorticoid receptor antagonist. This means it blocks the effects of cortisol at its receptor sites throughout the body, thereby reducing the impact of excess cortisol on various bodily functions, including glucose metabolism.
While Korlym can be highly effective in managing the challenging symptoms of Cushing's syndrome, particularly hyperglycemia, it is also associated with a wide range of potential side effects. Due to its mechanism of action, which involves interfering with a fundamental hormonal pathway, these side effects can be significant and require careful monitoring and management by healthcare professionals. Understanding these potential side effects, how to recognize them, and when to seek medical attention is crucial for anyone undergoing treatment with Korlym. This comprehensive guide aims to provide detailed information on the common, serious, and rare side effects associated with Korlym, along with advice on managing them and when to consult your doctor.
To fully appreciate the scope of Korlym's side effects, it's helpful to understand its mechanism of action. Mifepristone, the active ingredient in Korlym, is a synthetic steroid that acts as a potent antagonist at the progesterone and glucocorticoid receptors. In the context of Cushing's syndrome, its primary therapeutic effect comes from blocking glucocorticoid receptors. By doing so, it prevents cortisol from binding to these receptors and exerting its effects on target cells. This blockade helps to reduce the symptoms associated with cortisol excess, most notably hyperglycemia, by improving insulin sensitivity and reducing hepatic glucose production.
However, because glucocorticoid receptors are ubiquitous throughout the body and play critical roles in many physiological processes (e.g., metabolism, immune function, cardiovascular regulation, mood), blocking these receptors can lead to widespread effects, some of which are undesirable. Furthermore, mifepristone also has anti-progestational activity, which contributes to some of its unique side effects, particularly those related to the reproductive system in women. The balance between therapeutic benefit and potential adverse effects is a key consideration in prescribing and managing Korlym treatment.
Many individuals taking Korlym will experience some side effects, especially during the initial stages of treatment or with dose adjustments. These are generally mild to moderate in severity and may lessen over time as your body adjusts to the medication. It's important to discuss any side effects with your doctor, even if they seem minor, as they can sometimes be managed with simple interventions.
Always communicate any new or worsening side effects to your healthcare provider. They can help determine if the side effect is related to Korlym and advise on the best course of action.
While most side effects of Korlym are manageable, some can be serious or even life-threatening, requiring immediate medical attention. It is critical for patients and their caregivers to be aware of these potential serious adverse events.
Korlym can significantly lower potassium levels in the blood, which can be dangerous. Symptoms of severe hypokalemia include:
Your doctor will regularly monitor your potassium levels, especially before and during treatment. If hypokalemia occurs, potassium supplements or other medications may be prescribed. If you experience any severe symptoms of low potassium, seek emergency medical care immediately.
Korlym works by blocking cortisol receptors. While this is the intended therapeutic effect, it can sometimes lead to a state resembling adrenal insufficiency, where the body's response to stress is impaired due to insufficient cortisol signaling. This is particularly concerning if Korlym is stopped suddenly or if a patient experiences significant stress (e.g., surgery, severe infection).
Symptoms of adrenal insufficiency include:
Your doctor will monitor you for signs of adrenal insufficiency. If you need to stop taking Korlym, your doctor will likely taper the dose gradually. If you experience these symptoms, especially during times of stress or after stopping Korlym, contact your doctor immediately or seek emergency care.
Symptoms of QT prolongation or related arrhythmias may include:
Your doctor will perform an ECG before and periodically during treatment with Korlym. They will also check your electrolyte levels (potassium, magnesium). Korlym should not be used in patients with certain pre-existing heart conditions or those taking other medications known to prolong the QT interval. Report any symptoms of irregular heartbeats, dizziness, or fainting to your doctor immediately.
Korlym can cause elevations in liver enzymes, indicating liver injury. In rare cases, severe liver damage can occur.
Symptoms of liver problems include:
Your doctor will perform liver function tests (LFTs) before and regularly during your treatment. If you develop any of these symptoms, contact your doctor immediately.
Patients with Cushing's syndrome are already at an increased risk for blood clots. Korlym may further increase this risk. Blood clots can occur in the legs (deep vein thrombosis or DVT) or travel to the lungs (pulmonary embolism or PE), which can be life-threatening.
Symptoms of a blood clot in the leg (DVT) include:
Symptoms of a blood clot in the lung (PE) include:
If you experience any of these symptoms, seek emergency medical attention immediately.
While Korlym helps reduce the effects of excess cortisol, which can suppress the immune system, the drug itself can sometimes lead to an increased risk of infection. This is because normal glucocorticoid activity is crucial for immune function.
Symptoms of infection include:
Report any signs of infection to your doctor promptly.
Changes in mood and mental state can occur with Korlym treatment, potentially due to its effects on neurosteroid pathways or changes in cortisol signaling in the brain.
These can include:
If you or your family notice significant changes in mood, behavior, or thoughts, inform your doctor immediately.
Korlym can increase the risk of bleeding, particularly in women, due to its anti-progestational effects. This can manifest as heavy or prolonged menstrual bleeding, or abnormal vaginal bleeding. It can also increase the risk of bleeding in other areas, especially if you are taking blood thinners.
Symptoms include:
Report any unusual or excessive bleeding to your doctor.
While Korlym is used to *lower* high blood sugar in Cushing's patients, it can, in some instances, lead to hypoglycemia, especially if the patient is also on other diabetes medications (e.g., insulin, sulfonylureas). This is more likely as cortisol levels become better controlled.
Symptoms of hypoglycemia include:
If you are diabetic, your doctor will carefully monitor your blood glucose levels and may need to adjust the doses of your other diabetes medications. Learn to recognize the symptoms of hypoglycemia and how to treat it (e.g., with glucose tablets or sugary drinks) as advised by your doctor. Report frequent or severe episodes to your doctor.
Korlym (mifepristone) is metabolized by the enzyme CYP3A4 in the liver, and it also inhibits this enzyme. This means it can interact with a large number of other medications, potentially altering their effectiveness or increasing their side effects. It is crucial to inform your doctor about ALL medications you are taking, including over-the-counter drugs, herbal supplements, and vitamins.
As Korlym can prolong the QT interval, combining it with other medications that have the same effect significantly increases the risk of serious heart arrhythmias. Examples include certain antiarrhythmics (e.g., quinidine, procainamide, amiodarone, sotalol), antipsychotics, antidepressants, and some antibiotics (e.g., moxifloxacin). Concomitant use is contraindicated or requires extreme caution and close cardiac monitoring.
Korlym is a glucocorticoid receptor antagonist. Therefore, it will block the effects of exogenous (administered) corticosteroids. If a patient requires corticosteroid treatment for another condition (e.g., asthma, autoimmune disease), their effectiveness will be diminished by Korlym. This is an important consideration for patients needing stress-dose steroids during surgery or illness.
Since Korlym improves hyperglycemia, doses of insulin or oral hypoglycemic agents may need to be reduced to prevent hypoglycemia. Close monitoring of blood glucose is essential, especially when starting or adjusting Korlym.
Korlym may increase the anticoagulant effect of warfarin, increasing the risk of bleeding. Close monitoring of INR (International Normalized Ratio) is necessary if these drugs are used together.
Always provide your healthcare team with a complete list of all your medications to avoid potentially dangerous drug interactions.
Before starting Korlym, and throughout treatment, several important warnings and precautions must be considered to ensure patient safety.
Patients with severe liver or kidney impairment may require dose adjustments or closer monitoring, as Korlym's metabolism and excretion could be affected, leading to higher drug levels and increased risk of side effects.
Elderly patients may be more susceptible to the side effects of Korlym, particularly cardiovascular effects and electrolyte imbalances. Closer monitoring is often warranted in this population.
Patients with pre-existing conditions that increase the risk of hypokalemia (e.g., those on diuretics, or with severe diarrhea) should be monitored very closely.
Patients with a history of heart disease, arrhythmias, or other cardiovascular risk factors require careful evaluation and monitoring due to the risk of QT prolongation and other cardiac effects.
Patients with a history of depression or other psychiatric conditions should be closely monitored for worsening symptoms while on Korlym.
Regular monitoring is a cornerstone of safe Korlym treatment. This typically includes:
While regular follow-ups with your endocrinologist are essential for managing Korlym treatment, certain symptoms warrant immediate or urgent medical attention. Do not hesitate to contact your doctor or seek emergency care if you experience any of the following:
Always trust your instincts. If something feels wrong or you are concerned, it is always best to contact your healthcare provider.
A1: Korlym (mifepristone) is used to control hyperglycemia (high blood sugar) in adults with endogenous Cushing's syndrome who have type 2 diabetes mellitus or glucose intolerance, and who have failed surgery or are not candidates for surgery. It works by blocking the effects of excess cortisol in the body.
A2: Korlym acts as a glucocorticoid receptor antagonist. In patients with Cushing's syndrome, their bodies produce too much cortisol. By blocking the receptors where cortisol normally binds, Korlym prevents cortisol from exerting its effects, including those that lead to high blood sugar. This helps to improve insulin sensitivity and reduce the liver's production of glucose.
A3: The duration of side effects can vary greatly among individuals. Some common side effects, like nausea or fatigue, may be more pronounced when you first start taking the medication or after a dose adjustment, and might lessen over time as your body adjusts. However, more serious side effects can persist as long as you are taking the medication and require ongoing monitoring. Some side effects, like adrenal insufficiency, can even occur after stopping the medication, especially if it's stopped abruptly. Always discuss the persistence or severity of any side effect with your doctor.
A4: You should NEVER stop taking Korlym suddenly or without consulting your doctor. Abruptly stopping Korlym can lead to serious and potentially life-threatening adrenal insufficiency, as your body may not be able to produce enough cortisol to handle normal bodily functions or stress. If you are experiencing severe side effects, contact your doctor immediately. They may adjust your dose, prescribe other medications to manage the side effects, or develop a plan for safely discontinuing the medication if necessary.
A5: No, Korlym is contraindicated in pregnancy and during breastfeeding. It can cause termination of pregnancy due to its anti-progestational effects. Women of childbearing potential must use effective non-hormonal contraception during treatment and for at least one month after the last dose. It is not known if Korlym passes into breast milk, but due to the potential for serious adverse reactions in breastfed infants, breastfeeding is not recommended during treatment and for one month after the last dose.
A6: Due to the potential for serious side effects, close and regular monitoring is essential. This typically includes frequent blood tests to check potassium levels, liver function, and blood glucose. Electrocardiograms (ECGs) will also be performed periodically to monitor for QT prolongation. Your blood pressure will be regularly checked. For women of childbearing potential, pregnancy tests will be conducted before and during treatment. Your doctor will provide a detailed monitoring schedule tailored to your specific needs.
A7: Yes, Korlym can affect mood and mental health. Some patients have reported experiencing depression, anxiety, insomnia, or other mood changes. In rare cases, more severe psychiatric effects have been noted. If you or your family notice any significant changes in your mood, behavior, or thoughts, it is very important to inform your doctor immediately. They can assess the situation and recommend appropriate management strategies.
Korlym (mifepristone) is a valuable medication for managing hyperglycemia in specific adult patients with endogenous Cushing's syndrome, offering a targeted approach to counter the effects of excessive cortisol. However, its powerful mechanism of action means that it comes with a significant profile of potential side effects, ranging from common gastrointestinal disturbances and fatigue to serious and potentially life-threatening conditions such as hypokalemia, adrenal insufficiency, and cardiac arrhythmias.
Successful and safe treatment with Korlym hinges on a strong partnership between the patient and their healthcare team. This includes thorough pre-treatment evaluation, meticulous ongoing monitoring of blood work, ECGs, and vital signs, and open communication about any symptoms or concerns that arise. Patients must be vigilant in recognizing both common and serious side effects, understanding when to seek urgent medical attention, and adhering strictly to their prescribed regimen and monitoring schedule.
Understanding the potential risks and benefits, actively participating in your care, and maintaining regular dialogue with your doctor are paramount to safely and effectively managing Cushing's syndrome with Korlym. Never adjust your dose or stop taking the medication without explicit medical advice. Your healthcare provider is your best resource for personalized information and management strategies to navigate your treatment journey.
The information provided in this article is based on general medical knowledge and established pharmaceutical guidelines for Korlym (mifepristone). For specific, personalized medical advice and the most current drug information, always consult with your healthcare provider, pharmacist, and refer to the official prescribing information and patient information leaflets provided by the drug manufacturer and regulatory bodies like the FDA.
Visit Hospital
Near You
Learn about kidney transplant options in Narendrapur, recovery, and donor criteria. Expert insights for informed decisions.
May 19, 2026
Explore LASIK eye surgery in Madhepura. Learn about eligibility, the procedure, benefits, risks, and costs from trusted specialists.
May 19, 2026
Explore LASIK surgery in Nalanda. Understand eligibility, the procedure, recovery, and costs for vision correction at leading eye clinics.
May 19, 2026